FDA Inspection
Globus Medical, Inc.Globus Medical, Inc. – FDA Inspection, Aug 25, 2017
Record Details
This FDA Inspection record concerns Globus Medical, Inc., with an inspection on August 25, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ad02b27f-d448-4058-a873-136ff12dbdec
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1022878
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 820.100(b)Documentation
- 21 CFR 820.50(a)(2)Supplier oversight
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Globus Medical, Inc.
20| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2026 | Not classified | Philadelphia District Office | |
| August 13, 2026 | Not classified | Philadelphia District Office | |
| October 16, 2025 | VAI | Philadelphia District Office | Compliance: Medical Devices |
| March 7, 2024 | OAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| May 12, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Globus Medical, Inc.
- FDA Inspection 1327570 - 2026-08-21
- FDA Inspection 1291174 - 2026-08-13
- FDA Inspection 1253116 - 2025-10-16
- FDA Inspection 1230609 - 2024-03-07
- FDA Inspection 1170933 - 2022-05-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.